| Drug Name: | Zonisamide (68291-97-4) |
|---|---|
| PubChem ID: | 5734 |
| SMILES: | C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N |
| InchiKey: | UBQNRHZMVUUOMG-UHFFFAOYSA-N |
| Therapeutic Category: | Anticonvulsants, Antioxidants, Central Nervous System Agents, Protective Agents |
| Molecular Weight (dalton) | : | 212.23 |
| LogP | : | 0.6163 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 4 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 86.19 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Phenytoin (57-41-0) | Decreased Zonisamide Serum Level | Antagonistic | Uncertain | The necessity of adjusting the dosage of zonisamide when coadministered with other anti-epileptic drugs |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category